Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 7, Pages 1547
Publisher
MDPI AG
Online
2017-07-18
DOI
10.3390/ijms18071547
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- microRNA-577 suppresses tumor growth and enhances chemosensitivity in colorectal cancer
- (2017) Haiping Jiang et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Direct binding of microRNA-21 pre-element with Regorafenib: An alternative mechanism for anti-colorectal cancer chemotherapy?
- (2017) Xiaobing Chen et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2
- (2017) Peilong Li et al. MOLECULAR CANCER THERAPEUTICS
- First-line therapy for mCRC — the influence of primary tumour location on the therapeutic algorithm
- (2017) Chiara Cremolini et al. Nature Reviews Clinical Oncology
- Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer
- (2017) Sabine Tejpar et al. JAMA Oncology
- Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group
- (2016) D. P. Modest et al. ANNALS OF ONCOLOGY
- Prognostic and predictive significance of long interspersed nucleotide element-1 methylation in advanced-stage colorectal cancer
- (2016) Mami Kaneko et al. BMC CANCER
- Is regorafenib providing clinically meaningful benefits to pretreated patients with metastatic colorectal cancer?
- (2016) P. García-Alfonso et al. Clinical & Translational Oncology
- The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy
- (2016) James W.T. Toh et al. Clinical Colorectal Cancer
- The role of miR-126 in embryonic angiogenesis, adult vascular homeostasis, and vascular repair and its alterations in atherosclerotic disease
- (2016) Dimitry A. Chistiakov et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes
- (2016) Matthew W Rosenbaum et al. MODERN PATHOLOGY
- A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development
- (2016) Kenneth K.W. To et al. MOLECULAR CARCINOGENESIS
- From tumour heterogeneity to advances in precision treatment of colorectal cancer
- (2016) Cornelis J. A. Punt et al. Nature Reviews Clinical Oncology
- MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma
- (2016) Xiang Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer
- (2016) Lian Zhao et al. Oncotarget
- miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells
- (2016) Sofia E. Gomes et al. Oncotarget
- Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer
- (2016) Suk-young Lee et al. Biomed Research International
- The Clinical Significance of MiR-429 as a Predictive Biomarker in Colorectal Cancer Patients Receiving 5-Fluorouracil Treatment
- (2016) Sheng-jian Dong et al. MEDICAL SCIENCE MONITOR
- LncRNA—UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p
- (2016) Zehua Bian et al. Scientific Reports
- Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients
- (2015) Laura Lupini et al. BMC CANCER
- Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer
- (2015) T F Hansen et al. BRITISH JOURNAL OF CANCER
- MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer
- (2015) Cristina Caramés et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Combinational treatment with microRNA-133b and cetuximab has increased inhibitory effects on the growth and invasion of colorectal cancer cells by regulating EGFR
- (2015) JIANYU ZHOU et al. Molecular Medicine Reports
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy
- (2015) Yun-Ting Lou et al. PLoS One
- MicroRNA MIR21 and T Cells in Colorectal Cancer
- (2015) K. Mima et al. Cancer Immunology Research
- Association of MicroRNA-31-5p with Clinical Efficacy of Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer
- (2014) Hisayoshi Igarashi et al. ANNALS OF SURGICAL ONCOLOGY
- Serum miR-19a Predicts Resistance to FOLFOX Chemotherapy in Advanced Colorectal Cancer Cases
- (2014) Qi Chen et al. Asian Pacific Journal of Cancer Prevention
- Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients
- (2014) Camila Miranda Lopes-Ramos et al. BMC Medical Genomics
- Overexpression of MicroRNA-122 Re-sensitizes 5-FU-Resistant Colon Cancer Cells to 5-FU Through the Inhibition of PKM2 In Vitro and In Vivo
- (2014) Jinxia He et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2
- (2014) Chengli Du et al. Journal of Translational Medicine
- Tissue MicroRNAs as Predictors of Outcome in Patients with Metastatic Colorectal Cancer Treated with First Line Capecitabine and Oxaliplatin with or without Bevacizumab
- (2014) Mogens K. Boisen et al. PLoS One
- Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy
- (2013) Jian Zhang et al. ANTI-CANCER DRUGS
- Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro
- (2013) Jun Deng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-153 Supports Colorectal Cancer Progression via Pleiotropic Effects That Enhance Invasion and Chemotherapeutic Resistance
- (2013) L. Zhang et al. CANCER RESEARCH
- MicroRNA Signature in Metastatic Colorectal Cancer Patients Treated With Anti-EGFR Monoclonal Antibodies
- (2013) Federico Cappuzzo et al. Clinical Colorectal Cancer
- MicroRNAs targeting EGFR signalling pathway in colorectal cancer
- (2013) Jitka Mlcochova et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor
- (2013) Martin Pichler et al. JOURNAL OF CLINICAL PATHOLOGY
- Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment
- (2013) J.B. Kjersem et al. Molecular Oncology
- PTEN Loss Increases PD-L1 Protein Expression and Affects the Correlation between PD-L1 Expression and Clinical Parameters in Colorectal Cancer
- (2013) Minmin Song et al. PLoS One
- Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g
- (2013) Junius Salendo et al. RADIOTHERAPY AND ONCOLOGY
- miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer
- (2013) M Karaayvaz et al. Cell Death & Disease
- Clinical Outcomes of Patients with Microsatellite-Unstable Colorectal Carcinomas Depend on L1 Methylation Level
- (2012) Ye-Young Rhee et al. ANNALS OF SURGICAL ONCOLOGY
- miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells
- (2011) Ke Xu et al. MOLECULAR CARCINOGENESIS
- MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)
- (2010) N. Valeri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now